2,6-dichloro-4-acetylphenyl phosphate

Also Known As:

DCAPP

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Metabolic Bone Diseases (Osteopenia) 01/01/1999 - "This study was carried out to evaluate the clinical validity and usefulness of serum tartrate-resistant fluoride-sensitive acid phosphatase (TrFsACP) activity using 2,6-dichloro-4-acetylphenyl phosphate as substrate at pH 6.2 in metabolic bone diseases. "